In recent years, challenges such as COVID-19 have pushed pharmaceutical companies to find innovative solutions to accelerate their clinical trial timelines.
Amaury Jeandrain, Head of Business Development Engineering at N-SIDE, discusses in the Arena Clinical Trial Supply Handbook 2022 how an optimal supply chain can positively impact pharmaceutical companies and enable faster clinical trial timelines. In this article, Amaury outlines the importance for companies to accelerate their timelines and gives insights into how optimization of the supply chain helps eliminating its bottlenecks. |
Waste reduction has been a topic of discussion in pharmaceutical companies for many years and it has been identified has one of the causes of slower clinical trials timelines. However, whereas waste reduction is often coupled with cost reduction, Amaury explains that wasted drugs, when allocated efficiently, can also be enablers of faster timelines .
"What generates waste is not only the planning, but the constraints that the supply chain must work with." - Amaury Jeandrain
In this article, you can also learn more about:
If you are interested to know more about the challenges of faster clinical trial timelines and how companies can learn to optimize their supply chain, you can read Amaury's full article here.
Hear from Biotech industry experts how challenges in clinical trial supply and manufacturing can be overcome with innovative software solutions.
Download it now!Clinical trial supply optimization is the process of supplying the right amount of investigational medicinal product (IMP) and comparators to all trial sites so all patients receive their doses on schedule. Learn more it and how it can benefit you in this article.
Read nowLot sizing in clinical trials manufacturing can save more than you think! Testing different lot size scenarios can reduce manufacturing costs and drug waste. We explain how using real-world examples in this resource.
Download it now!